132 related articles for article (PubMed ID: 37080855)
1. Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity.
Camps-Malea A; Pointreau Y; Chapet S; Calais G; Barillot I
Cancer Radiother; 2023 May; 27(3):225-232. PubMed ID: 37080855
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series.
Leonetti A; D'Abbiero N; Baldari G; Andreani S; Ruffini L; Viansone AA; Buti S
Int J Urol; 2018 Oct; 25(10):879-886. PubMed ID: 30103254
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy of Lymph Node Oligometastases.
Burkoň P; Oberreiterová S; Kazda T; Slávik M; Bobek L; Komínek L; Procházka T; Vrzal M; Šlampa P
Klin Onkol; 2020; 33(2):114-122. PubMed ID: 32303132
[TBL] [Abstract][Full Text] [Related]
4. Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis.
Nicosia L; Franzese C; Mazzola R; Franceschini D; Rigo M; D'agostino G; Corradini S; Alongi F; Scorsetti M
Strahlenther Onkol; 2020 Mar; 196(3):213-221. PubMed ID: 31559480
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer : An investigation of 117 pelvic lymph nodes.
Cozzi S; Botti A; Timon G; Blandino G; Najafi M; Manicone M; Bardoscia L; Ruggieri MP; Ciammella P; Iotti C
Strahlenther Onkol; 2022 Aug; 198(8):700-709. PubMed ID: 34757443
[TBL] [Abstract][Full Text] [Related]
6. Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.
Manabe Y; Shibamoto Y; Baba F; Yanagi T; Iwata H; Miyakawa A; Murai T; Okuda K
Jpn J Radiol; 2018 Dec; 36(12):719-725. PubMed ID: 30218253
[TBL] [Abstract][Full Text] [Related]
7. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
Yeung R; Hamm J; Liu M; Schellenberg D
Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.
Meng MB; Wang HH; Zaorsky NG; Zhao XZ; Wu ZQ; Jiang B; Song YC; Zhuang HQ; Li FT; Zhao LJ; Wang CL; Li K; Wang P; Yuan ZY
Oncotarget; 2015 Jun; 6(17):15690-703. PubMed ID: 25881546
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes.
Wang HH; Zaorsky NG; Meng MB; Zeng XL; Deng L; Song YC; Zhuang HQ; Li FT; Zhao LJ; Yuan ZY; Wang P; Hao XS
Oncotarget; 2016 Apr; 7(14):18135-45. PubMed ID: 26919113
[TBL] [Abstract][Full Text] [Related]
10. Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
Franzese C; Franceschini D; Di Brina L; DʼAgostino GR; Navarria P; Comito T; Mancosu P; Tomatis S; Scorsetti M
J Urol; 2019 Jan; 201(1):70-75. PubMed ID: 30577391
[TBL] [Abstract][Full Text] [Related]
11. Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer.
Loi M; Di Cataldo V; Francolini G; Bonomo P; Masi L; Simontacchi G; Detti B; Greto D; Desideri I; Livi L
Oncol Res Treat; 2018; 41(11):703-705. PubMed ID: 30317236
[TBL] [Abstract][Full Text] [Related]
12. Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.
Jereczek-Fossa BA; Piperno G; Ronchi S; Catalano G; Fodor C; Cambria R; Fossati Ing P; Gherardi F; Alterio D; Zerini D; Garibaldi C; Baroni G; De Cobelli O; Orecchia R
Am J Clin Oncol; 2014 Jun; 37(3):227-33. PubMed ID: 22992626
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G; Nardangeli A; Laliscia C; Fodor A; Draghini L; Gentile PC; D'Agostino GR; Balcet V; Bonome P; Ferioli M; Autorino R; Vicenzi L; Raguso A; Borghesi S; Ippolito E; Di Cataldo V; Cilla S; Perrucci E; Campitelli M; Gambacorta MA; Deodato F; Scambia G; Ferrandina G
Int J Gynecol Cancer; 2022 Jun; 32(6):732-739. PubMed ID: 35193941
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience.
Ingrosso G; Trippa F; Maranzano E; Carosi A; Ponti E; Arcidiacono F; Draghini L; Di Murro L; Lancia A; Santoni R
World J Urol; 2017 Jan; 35(1):45-49. PubMed ID: 27233779
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
[TBL] [Abstract][Full Text] [Related]
16. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.
Ost P; Jereczek-Fossa BA; Van As N; Zilli T; Tree A; Henderson D; Orecchia R; Casamassima F; Surgo A; Miralbell R; De Meerleer G
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e115-20. PubMed ID: 27133946
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.
Matsushita H; Jingu K; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Katagiri Y; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803597. PubMed ID: 30352542
[TBL] [Abstract][Full Text] [Related]
18. Locoregional control and survival after lymph node SBRT in oligometastatic disease.
Loi M; Frelinghuysen M; Klass ND; Oomen-De Hoop E; Granton PV; Aerts J; Verhoef C; Nuyttens J
Clin Exp Metastasis; 2018 Oct; 35(7):625-633. PubMed ID: 29995254
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
[TBL] [Abstract][Full Text] [Related]
20. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
Jereczek-Fossa BA; Beltramo G; Fariselli L; Fodor C; Santoro L; Vavassori A; Zerini D; Gherardi F; Ascione C; Bossi-Zanetti I; Mauro R; Bregantin A; Bianchi LC; De Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):889-97. PubMed ID: 21277113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
